December 28th – The network of institutions of Parcare, a health agency in New York State, is under joint investigation by the State of New York for alleged violations of vaccination plans to provide vaccination to individuals. The health agency said it would return the remaining coronavirus vaccine to the New York State health department.
According to the ABC on the 27th, New York police and other investigators raided the ParCare branch in Borough Park on Saturday night (26th) local time to determine whether it circumvented regulations under the current New York guidelines to provide coronavirus vaccination to the public who have not been prioritized for distribution.
Service. Under New York State regulations, only medical personnel, first responders and nursing home workers are currently allowed to be vaccinated against the novel coronavirus.
Other groups of people will be vaccinated in subsequent rounds. The New York State Department of Health statement stressed that ParCare’s actions were in violation of the state vaccination program, which officials “take very seriously, and the health department will join the state police in conducting a criminal investigation into the case”.
Earlier, ParCare promoted the vaccine on its social media, claiming that these vaccines only apply to people who are “older people”, “high risk” or “basic diseases” can be provided to other groups on a “first come, first served” basis.
After investigation, a spokesman for ParCare said that ParCare received 2,300 doses of Moderna coronavirus vaccine, of which 869 had been vaccinated, and the remaining vaccines would be returned to the state health department.
The spokesman stressed that ParCare obtained the vaccine by following New York State procedures, with the approval of the New York State Department of Health, and as the distribution point of the Centers for Disease Control and Prevention, is now sending relevant documents to the New York State Department of Health.
On December 14, the United States began to use the coronavirus vaccine jointly developed by Pfizer and BioNTech.
Later, the coronavirus vaccine of Moderna was also approved.
